Publications by authors named "Mu-wen Wang"

7 Publications

  • Page 1 of 1

[Focusing on MRI-suspected lesions in targeted transrectal prostate biopsy guided by MRI-TRUS fusion imaging for the diagnosis of prostate cancer].

Zhonghua Nan Ke Xue 2016 Sep;22(9):782-786

Shandong Research Institute of Medical Imaging, Jinan, Shandong 50021, China.

Objective: To improve the accuracy of prostate cancer (PCa) detection by focusing biopsy on the suspected lesion manifested by MRI with the total number of biopsy cores relatively unchanged.

Methods: A prospective randomized analysis was performed on 262 cases of suspected PCa detected by multi-parametric MRI (mp-MRI), each with a single suspected lesion with 10 μg/L≤ PSA <20 μg/L. All the patients underwent targeted transrectal prostate biopsy guided by fusion imaging of MRI with transrectal ultrasonography (TRUS), using the 6X+6 strategy (6 cores in the suspected region and another 6 in the systematic prostate) for 134 cases and the traditional 12+2X method (12 cores in the systematic prostate and 2 in the suspected region) for the other 128. Comparisons were made between the two methods in the PCa detection rate in the cases of suspected lesion, total PCa detection rate, incidence of post-biopsy complications, and Gleason scores. Analyses were performed on the prostate imaging reporting and data system (PI-RADS) score, location, transverse section, and diameter of the suspected lesion.

Results: Both the total PCa detection rate and that in the cases of suspected lesion were significantly higher in the 6X+6 (44.8% and 37.3%) than in the 12+2X group (37.5% and 27.3%) (P<0.05). MRI showed that the suspected lesions were mostly (45%) located in the middle part of the prostate, the mean area of the transverse section was (0.48±0.11) cm2, and the mean diameter of the tumor was (8.51±2.21) mm. The results of biopsy showed that low-grade tumors (Gleason 3+3=6) accounted for 68% in the 6X+6 group and 71% in the 12+2X group. No statistically significant differences were found between the two groups in the incidence rate of post-biopsy complications.

Conclusions: Compared with the traditional 12+2X method, for the suspected lesion manifested by mp-MRI, focusing biopsy on the suspected region with the 6X+6 strategy can achieve a higher PCa detection rate without increasing the incidence of complications.
View Article and Find Full Text PDF

Download full-text PDF

Source
September 2016

PlncRNA-1 induces apoptosis through the Her-2 pathway in prostate cancer cells.

Asian J Androl 2017 Jul-Aug;19(4):453-457

Minimally Invasive Urology Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, PR China.

To determine whether PlncRNA-1 induces apoptosis in prostate cancer cells through the Her-2 pathway. The expression of PlncRNA-1, Her-2, and related cyclin proteins in 23 cases of prostate cancer and adjacent normal tissues was analyzed and compared. LNCaP cells were divided into a control group and an LNCaP-PlncRNA-1-siRNA experimental group. Normal prostate RWPE-1 cells were divided into an RWPE-1 control group and an RWPE-1-PlncRNA-1 experimental group. After PlncRNA-1 silencing and overexpression, changes in Her-2 and cyclinD1 expression levels were detected both in vivo and in vitro. In prostate cancer tissues, Her-2 and PlncRNA-1 were highly expressed and significantly correlated. In LNCaP cells, the expression of Her-2 and cyclinD1 decreased following the downregulation of PlncRNA-1 as assessed by real-time PCR and Western blotting. In RWPE-1 cells, the expression of Her-2 and cyclinD1 increased following PlncRNA-1 overexpression. Flow cytometry revealed that the proportion of LNCaP cells in G2/M phase was significantly increased after PlncRNA-1 silencing and that the proportion of RWPE-1 cells in G2/M phase was significantly decreased after PlncRNA-1 overexpression. Furthermore, animal experiments validated these results. In conclusion, in prostate cancer, PlncRNA-1 regulates the cell cycle and cyclinD1 levels and can also regulate proliferation and apoptosis in prostate cancer cells through the Her-2 pathway.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.4103/1008-682X.178849DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507092PMC
March 2018

Prostatic stromal tumor of uncertain malignant potential presenting as a huge bladder mass: an unusual case.

Asian J Androl 2014 Sep-Oct;16(5):794-5

Minimally Invasive Urology Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.4103/1008-682X.131070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215655PMC
June 2015

Assessment of tamsulosin as a potential male contraceptive in healthy volunteers.

Urology 2012 Sep 26;80(3):614-7. Epub 2012 Jul 26.

Department of Minimally Invasive Urology Center, Provincial Hospital Affiliated to Shandong University, Ji'nan, Shandong Province, China.

Objective: To investigate the efficacy and safety of tamsulosin, an α(1A)-adrenoceptor antagonist, as a potential male contraceptive.

Methods: Forty healthy male volunteers were equally divided into 2 groups, each of which received placebo and tamsulosin sequentially in a crossover manner. Ejaculatory profile was examined 4 to 6 hours after administration and adverse effects were noted.

Results: Anejaculation occurred in all subjects after taking 0.8-mg of tamsulosin. Total functional sperm count was significantly reduced in subjects after taking 0.4-mg of tamsulosin. Six subjects receiving 0.8-mg of tamsulosin complained of tolerated discomfort, which disappeared 10 hours after administration.

Conclusion: When administered at 0.8 mg, tamsulosin can cause anejaculation with some transient side effects. Our results imply that tamsulosin and related drugs might potentially be used as male contraceptive agents in the future, which needs more studies to verify.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2012.06.003DOI Listing
September 2012

Robot assisted transperitoneal laparoscopic pyeloplasty.

Chin Med J (Engl) 2008 Feb;121(4):380-2

Minimally Invasive Urology Center, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.

View Article and Find Full Text PDF

Download full-text PDF

Source
February 2008

[Transperitoneal laparoscopic enucleation of renal angiomyolipoma: a report of 10 cases].

Zhonghua Wai Ke Za Zhi 2005 Sep;43(18):1212-4

Endo-urologic Mininvasive Medicine Center, Shandong Provincial Hospital, Shandong University, Jinan 250021, China.

Objective: To evaluate the feasibility and clinical effect of transperitoneal laparoscopic enucleation of renal angiomyolipoma (RAML) without obstruction of renal pedicle.

Methods: Ten patients with renal angioleiomyoma (tumor diameter < 4 cm) were operated by transperitoneal laparoscopy without obstruction of renal pedicle. The operating time, blood loss, hospital stay after operation, intraoperative and postoperative complications and the operative effect were observed.

Results: All the 10 patients underwent the operation successfully. The average operating time was 90 min, average blood loss was 80 ml, the average hospital stay after operation was 7 d. No intraoperative or postoperative complications occurred. Follow-up period was 3-19 months and no tumor metastasized or occurred again.

Conclusion: This mininvasive procedure is a more precise and complete method than before, which can minimize the blood loss and make patients recover quickly, so it is well worth clinical applying.
View Article and Find Full Text PDF

Download full-text PDF

Source
September 2005

[Chronic pelvic pain syndrome].

Zhonghua Nan Ke Xue 2002 ;8(5):359-62

Department of Urology, Shangdong Provincial Hospital, Jinan, Shandong 250021, China.

Chronic pelvic pain syndrome(CPPS) which is also named by chronic nonbacterial prostatitis is a common urologic disease. This disease could not be treated effectively and affects the living quality of the patients. This article reviews the progress on the CPPS about its definition, classification, etiology (e.g. immunology), diagnosis and treatment in recent years.
View Article and Find Full Text PDF

Download full-text PDF

Source
January 2003
-->